Trial Profile
A randomized, open-label, single dose, 2-way crossover study to evaluate the pharmacokinetic characteristics of EL-1401 in comparison to the co-administration of nebivolol and rosuvastatin in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Nebivolol/rosuvastatin (Primary) ; Nebivolol; Rosuvastatin
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- Sponsors Elyson Pharm
- 19 Jun 2017 Status changed from active, no longer recruiting to completed.
- 05 May 2017 New trial record